Evaluation of medicinal products for cardiovascular disease prevention - Scientific guideline
Table of contents
This document provides guidance for the clinical evaluation of drugs in the prevention of cardiovascular events.
Keywords: Cardiovascular prevention, risk scoring models, SCORE system, Framingham risk score
-
List item
Overview of comments received on draft guideline on the evaluation of medicinal products for cardiovascular disease prevention (EMEA/CHMP/EWP/311890/2007) (PDF/105.13 KB)
First published: 24/07/2008
Last updated: 24/07/2008
EMEA/CHMP/EWP/357298/2008 -
List item
Draft guideline on the evaluation of medicinal products for cardiovascular disease prevention (PDF/50.29 KB)
Draft: consultation closed
First published: 19/07/2007
Last updated: 19/07/2007
EMEA/CHMP/EWP/311890/2007 -
List item
Concept paper on the development of a committee for medicinal products for human use (CHMP) note for guidance on the need for regulatory guidance in the evaluation of medicinal products for the secondary cardiovascular p... (PDF/134.84 KB)
First published: 23/06/2004
Last updated: 23/06/2004
CHMP/EWP/1470/04